Showcasing Groundbreaking HIV/AIDS Research

The AIDS2024 conference, held from July 22 to 26 in Munich, has been a significant event for researchers and professionals in the field of HIV/AIDS. This year's conference saw active participation from the KAVI-ICR team and the Department of Medical Microbiology, who presented their groundbreaking research and contributed to various sessions, showcasing their commitment to advancing HIV/AIDS research.

The Department of Medical Microbiology and KAVI-ICR team, led by Dr. Marianne Mureithi, played a crucial role in covering this Mucosal Immunology sessions, highlighting the importance of mucosal immunity in the context of HIV prevention.

Other Key Sessions

Dynamic Interplay of High-Risk Human Papillomavirus in Women Living with HIV

**Presenter:** James Kangethe, Kenyatta National Hospital 

James Kangethe a PhD scholar from the Department and also Kenyatta National Hospital presented on the dynamic interplay of high-risk human papillomavirus in women living with HIV, focusing on persistence, clearance, incidence, and synergies with human T-lymphotropic virus-1 infections in a Kenyan teaching referral hospital.

Notable Attendees and Contributions

The conference also featured prominent figures such as Carlos Diazgranados from the Bill & Melinda Gates Foundation and Marianne Mureithi from the University of Nairobi, Kenya. Dr. Mureithi, a significant contributor to understanding HIV transmission and prevention, represented the Department of Medical Microbiology and highlighted the ongoing research efforts and collaborations.

Collaborative Efforts and Networking

KAVI-ICR team members engaged in numerous sessions, workshops, and interactive Q&A segments, fostering collaboration and knowledge exchange. The conference provided an excellent platform for networking with global experts, sharing insights, and exploring new research avenues.

Conference Highlights

- Panel Discussions: Engaging panel discussions on various aspects of HIV/AIDS research, policy, and community impact.

- Research Presentations:Detailed presentations on cutting-edge research and innovative strategies for HIV prevention and treatment.

- Networking Opportunities: Valuable opportunities to connect with peers, experts, and stakeholders in the field.

Conclusion

The participation of KAVI-ICR and the Department of Medical Microbiology at the AIDS2024 conference underscored their commitment to advancing HIV/AIDS research. Their presentations and active engagement in various sessions highlighted their pivotal role in the global fight against HIV/AIDS. As the conference continues, the KAVI-ICR team remains dedicated to pushing the boundaries of research and fostering collaborations that will lead to significant breakthroughs in HIV prevention and treatment.

For more updates and detailed insights from the conference, stay tuned to our website and social media channels.